Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 1253K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Van Etten, R. A. Search for Related Content PubMed PubMed Citation Articles by Van Etten, R. A. Social Bookmarking                            What's this?

CORRESPONDENCE R.A.V.: rvanetten{at}tufts-nemc.org

ABSTRACT
Chronic myeloid leukemia (CML), which is caused by the BCR–ABL fusion tyrosine kinase, is one of the most intensively studied human cancers. ABL kinase inhibitors have been spectacularly successful in treating CML, but disease persistence and acquired drug resistance can prevent eradication and cure of the leukemia. The development of better therapies will depend on a full understanding of signaling pathways in CML, facilitated by model studies using mutant mice.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Brehme, M., Hantschel, O., Colinge, J., Kaupe, I., Planyavsky, M., Kocher, T., Mechtler, K., Bennett, K. L., Superti-Furga, G. (2009). Charting the molecular network of the drug target Bcr-Abl. Proc. Natl. Acad. Sci. USA 106: 7414-7419 [Abstract] [Full Text]  
• Yu, W., Sun, X., Clough, N., Cobos, E., Tao, Y., Dai, Z. (2008). Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivo. Carcinogenesis 29: 1717-1724 [Abstract] [Full Text]  
• Ban, K., Gao, Y., Amin, H. M., Howard, A., Miller, C., Lin, Q., Leng, X., Munsell, M., Bar-Eli, M., Arlinghaus, R. B., Chandra, J. (2008). BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia. Blood 111: 2904-2908 [Abstract] [Full Text]  
• Van Etten, R. A. (2007). Oncogenic signaling: new insights and controversies from chronic myeloid leukemia. JCB 176: i14-i14 [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS